I Don't Believe in Imaginary Property writes "A Facebook employee has given a tell-all interview with some very interesting things about Facebook's internals. Especially interesting are all the things relating to Facebook privacy. Basically, you don't have any. Nearly everything you've ever done on the site is recorded into a database. While they fire employees for snooping, more than a few have done it. There's an internal system to let them log into anyone's profile, though they have to be able to defend their reason for doing so. And they used to have a master password that could log into any Facebook profile: 'Chuck Norris.' Bruce Schneier might be jealous of that one."

lwbrown writes with this excerpt from Government Computer News about a concept being explored at Oak Ridge National Laboratory: "UNTAME is the product of a long-term program by the division's Cyber Security and Information Intelligence Research Group to develop futuristic security functionality for increasingly large, complex environments. The cybots differ from traditional software agents in that they form a collective and are aware of the condition and activities of other cybots in the collective. 'You give it a mission and tools to work with, such as mobility and intrusion sensors, and it uses those tools and cooperates with other cybots to accomplish the mission," said Lawrence MacIntyre, one of the project's developers.'"

Soychemist writes "Some people have a mutation that makes them highly resistant to HIV, and scientists think that they can give that immunity to anyone with a new type of gene therapy. The first human trials will start at the University of Pennsylvania this week. Researchers will draw blood from people with drug-resistant HIV, clip the CCR5 gene out of their T-cells with a nuclease enzyme, grow the modified cells in a dish, and then return 10 billion of them to the patient's bloodstream. Those cells will be immune to the virus, and they will keep the patient's T-cell count up even if the rest are destroyed. 'We will see if it is safe and if those cells inhibit HIV replication in vivo,' said the lead researcher. 'We know they do in the test tube.'"